Richard D. Dinnen

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Robert L. Fine, Anthony P. Gulati, Benjamin A. Krantz et al. · Cancer Chemotherapy and Pharmacology · 2013 · 257 citations

Medicine, Oncology, Pharmacology +16

Selective induction of apoptosis through the FADD/caspase‐8 pathway by a p53 c‐terminal peptide in human pre‐malignant and malignant cells

Yin Li, Yuehua Mao, Ramon Rosal et al. · International Journal of Cancer · 2005 · 31 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Activation of Targeted Necrosis by a p53 Peptide

Richard D. Dinnen, Lisa Drew, Daniel P. Petrylak et al. · Journal of Biological Chemistry · 2007 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

Redirecting Apoptosis to Aponecrosis Induces Selective Cytotoxicity to Pancreatic Cancer Cells through Increased ROS, Decline in ATP Levels, and VDAC

Richard D. Dinnen, Yuehua Mao, Wanglong Qiu et al. · Molecular Cancer Therapeutics · 2013 · 22 citations

Medicine, Oncology, Pharmacology +17

The Use of Fluorescent Probes in the Study of Reactive Oxygen Species in Pancreatic Cancer Cells

Richard D. Dinnen, Yuehua Mao, Robert L. Fine · Methods in molecular biology · 2012 · 10 citations

Life Sciences, Cell Biology, Oncology +17